Australia markets closed

CervoMed Inc. (CRVO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.50-0.37 (-2.33%)
At close: 04:00PM EDT
15.50 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 127.93M
Enterprise value 121.56M
Trailing P/E 115.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)23.97
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.64

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3257.55%
S&P500 52-week change 326.25%
52-week high 326.38
52-week low 33.00
50-day moving average 320.82
200-day moving average 314.21

Share statistics

Avg vol (3-month) 348.89k
Avg vol (10-day) 3144.36k
Shares outstanding 58.25M
Implied shares outstanding 68.25M
Float 83.79M
% held by insiders 135.19%
% held by institutions 134.87%
Shares short (14 June 2024) 4181.89k
Short ratio (14 June 2024) 45.7
Short % of float (14 June 2024) 43.40%
Short % of shares outstanding (14 June 2024) 42.20%
Shares short (prior month 15 May 2024) 4126.52k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Dec 2018
Ex-dividend date 4N/A
Last split factor 22:3
Last split date 317 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -51.36%
Operating margin (ttm)-110.55%

Management effectiveness

Return on assets (ttm)-90.48%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)8.08M
Revenue per share (ttm)1.98
Quarterly revenue growth (yoy)66.70%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-4.15M
Diluted EPS (ttm)-0.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.37M
Total cash per share (mrq)0.77
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.99
Book value per share (mrq)0.87

Cash flow statement

Operating cash flow (ttm)-7.39M
Levered free cash flow (ttm)-4.65M